PDCD1 and neoplasm: Indeed, combination of FOXO1-ADA expressing CAR T cells with anti-PD-1 resulted in significantly improved tumour growth inhibition compared with control CAR T cells, suggesting synergy between FOXO1-ADA CAR T cells and PD-1 blockade (Extended Data Fig. 5d).